Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

HRTSvsAGNGETF Comparison

ETF 1
HRTS

Tema GLP-1, Obesity & Cardiometabolic ETF

This fund is part of
Tomorrow's Treatments
+1.34%
VS
ETF 2
AGNG

Global X Aging Population ETF

This fund is part of
New Consumers & Focus
+1.22%

Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS) belongs to the Tomorrow's Treatments segment. Global X Aging Population ETF (AGNG) is part of the New Consumers & Focus segment. Both ETFs have the same top 3 sector exposures: and Healthcare. HRTS is more expensive with a Total Expense Ratio (TER) of 0.99%, versus 0.5% for AGNG. HRTS is up 4.32% year-to-date (YTD) with -$2M in YTD flows. AGNG performs better with 4.95% YTD performance, and +$13M in YTD flows. Run a side-by-side ETF comparison of HRTS and AGNG below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

HRTS vs AGNG performance and flow charts

Performance

-1.00.01.02.03.04.05.0%Jun 30Jul 8Jul 15Jul 22Jul 29

Cumulative Flows

Jun 30Jul 8Jul 15Jul 22Jul 29

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/30/2026
1M3MYTD1Y3Y5Y
Perf.
HRTS
AGNG
+1.63%+4.11%
+9.49%+7.07%
+4.32%+4.95%
+31.36%+16.31%
n/a+37.15%
n/a+28.43%
Flows
HRTS
AGNG
--
-$70K+$692K
-$2M+$13M
-$6M+$18M
-+$23M
-+$13M
Volatility and drawdown
3M1Y3Y5Y
Volatility
HRTS
AGNG
+17.44%+14.86%
+16.04%+13.13%
n/a+12.28%
n/a+13.80%
Max drawdown
HRTS
AGNG
-4.69%-4.89%
-10.68%-11.18%
n/a-13.73%
n/a-25.40%
Max drawdown duration
HRTS
AGNG
23d31d
170d151d
n/a323d
n/a1041d
Trading data

Create an account to view trading data

Join for free
HRTS
AGNG
Last sale
7/31/2026 at 1:30 PM
$36.43
$37.19
Previous close
07/30/2026
$36.90
$37.56
Consolidated volume
07/30/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

HRTS
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
HRTS
AGNG
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/31/2026 at 1:30 PM
Live
Closed
HRTS
AGNG
Last price
$36.43
$37.19
1D performance
-1.26%
-0.99%
AuM$54.92 M$87.98 M
E/R0.99%0.5%
Characteristics
HRTS
AGNG
Management strategyActivePassive
ProviderTemaGlobal X
Benchmark-Indxx Aging Population Thematic Index
N° of holdings4384
Asset class--
Trailing 12m distribution yield
Join
Join
Inception dateNovember 21, 2023May 9, 2016
ESGNoYes
Advertisement
Exposure

Countries

HRTS
USA
76.55%
Switzerland
7.26%
Other
16.19%
AGNG
USA
55.01%
Switzerland
13.28%
Other
31.7%

Sectors

HRTS
Healthcare
99.57%
Other
0.43%
AGNG
Healthcare
90.38%
Finance
9.07%
Other
0.55%

Diversification

HRTS

Total weight of top 15 holdings out of 15

64.29%
AGNG

Total weight of top 15 holdings out of 15

47.54%

Top 15 holdings

Data as of June 30, 2026
HRTS
Eli Lilly & Co.
11.91%
UnitedHealth Group, Inc.
5.58%
Novo Nordisk A/S
5.25%
Merck & Co., Inc.
4.11%
Roche Holding AG
3.96%
Thermo Fisher Scientific, Inc.
3.91%
AstraZeneca PLC
3.85%
Johnson & Johnson
3.84%
Revolution Medicines, Inc.
3.64%
Cytokinetics, Inc.
3.40%
Novartis AG
3.30%
Gilead Sciences, Inc.
3.09%
Vertex Pharmaceuticals, Inc.
3.04%
Abbott Laboratories
2.71%
Danaher Corp.
2.70%
AGNG
Novo Nordisk A/S
3.84%
Eli Lilly & Co.
3.82%
AbbVie, Inc.
3.57%
Edwards Lifesciences Corp.
3.42%
Welltower, Inc.
3.29%
Johnson & Johnson
3.19%
Merck & Co., Inc.
3.13%
Ventas, Inc.
3.11%
Roche Holding AG
3.05%
Amgen, Inc.
3.01%
Bristol Myers Squibb Co.
2.92%
Stryker Corp.
2.88%
UCB SA
2.81%
AstraZeneca PLC
2.76%
Medtronic Plc
2.73%
Frequently asked questions about HRTS and AGNG

How have the HRTS and AGNG ETFs performed in 2026?

As of July 30, 2026, HRTS is up 4.32% year-to-date (YTD), while AGNG has returned 4.95%. That puts AGNG better performer ahead so far this year.

Which ETF is attracting more investor money: HRTS or AGNG?

Year-to-date, the HRTS ETF saw -$2M in flows, compared to +$13M for AGNG.

Which ETF is more volatile: HRTS or AGNG?

Over the past year, HRTS had a volatility of 16.04%, while AGNG experienced 13.13%.

Which ETF is bigger: HRTS or AGNG?

As of July 30, 2026, HRTS holds $54.92 M in assets under management (AUM), while AGNG manages $87.98 M.

What sectors do the HRTS and AGNG ETFs invest in?

HRTS leans toward sectors like Healthcare. Meanwhile, AGNG focuses on Healthcare and Finance.

What are the top holdings of the HRTS ETF and AGNG ETF?

HRTS top holdings include Eli Lilly & Co., UnitedHealth Group, Inc. and Novo Nordisk A/S. AGNG holds in its top three: Novo Nordisk A/S, Eli Lilly & Co. and AbbVie, Inc..

Which ETF is more diversified: HRTS or AGNG?

HRTS holds 43 securities with 64.29% of its assets in the top 15. AGNG has 84 securities and a top 15 weight of 47.54%.

Advertisement
Advertisement
Advertisement
ETF Comparison Tool

Have you tried our ETF Compare tool?

Compare ETFs like a pro. Analyze fees, performance, exposure & holdings side-by-side.